BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 33172936)

  • 1. Association between Use of Hydrochlorothiazide and Risk of Keratinocyte Cancers in Kidney Transplant Recipients.
    Letellier T; Leborgne F; Kerleau C; Gaultier A; Dantal J; Ville S;
    Clin J Am Soc Nephrol; 2020 Dec; 15(12):1804-1813. PubMed ID: 33172936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-melanoma skin cancer in Portuguese kidney transplant recipients - incidence and risk factors.
    Pinho A; Gouveia M; Cardoso JC; Xavier MM; Vieira R; Alves R
    An Bras Dermatol; 2016; 91(4):455-62. PubMed ID: 27579740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin Cancer Development in Solid Organ Transplant Recipients in Switzerland (Swiss Transplant Cohort Study).
    Stenz NA; Stampf S; Arnold AW; Cozzio A; Dickenmann M; Gaide O; Harms M; Hunger RE; Laffitte E; Mühlstädt M; Nägeli M; Hofbauer GFL;
    Dermatology; 2021; 237(6):970-980. PubMed ID: 33227788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between hydrochlorothiazide and the risk of in situ and invasive squamous cell skin carcinoma and basal cell carcinoma: A population-based case-control study.
    Adalsteinsson JA; Muzumdar S; Waldman R; Hu C; Wu R; Ratner D; Ungar J; Silverberg JI; Olafsdottir GH; Kristjansson AK; Tryggvadottir L; Jonasson JG
    J Am Acad Dermatol; 2021 Mar; 84(3):669-675. PubMed ID: 32791082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for Keratinocyte Carcinoma in Recipients of Allogeneic Hematopoietic Cell Transplants.
    Scott JF; Brough KR; Grigoryan KV; Muzic JG; Kim GY; Conic RRZ; Hill ST; Brewer JD; Baum CL; Litzow MR; Hogan WJ; Patnaik MS; Hashmi SK; Lazarus HM; Bordeaux JS; Thompson CL; Gerstenblith MR; Lehman JS
    JAMA Dermatol; 2020 Jun; 156(6):631-639. PubMed ID: 32267479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subsequent squamous- and basal-cell carcinomas in kidney-transplant recipients after the first skin cancer: cumulative incidence and risk factors.
    Wisgerhof HC; Edelbroek JR; de Fijter JW; Haasnoot GW; Claas FH; Willemze R; Bavinck JN
    Transplantation; 2010 May; 89(10):1231-8. PubMed ID: 20410852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Use of Hydrochlorothiazide and Risk of Skin Cancer in Caucasian Adults: A PharmLines Initiative Inception Cohort Study.
    Haisma MS; Greven N; Logendran M; Bos J; van der Vegt B; Horváth B; De Vos S; De Bock GH; Hak E; Rácz E
    Acta Derm Venereol; 2023 Apr; 103():adv3933. PubMed ID: 37014269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark.
    Pedersen SA; Gaist D; Schmidt SAJ; Hölmich LR; Friis S; Pottegård A
    J Am Acad Dermatol; 2018 Apr; 78(4):673-681.e9. PubMed ID: 29217346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoplastic skin lesions in Iranian renal transplant recipients: the role of immunosuppressive therapy.
    Zamanian A; Farshchian M
    J Drugs Dermatol; 2007 Jul; 6(7):703-6. PubMed ID: 17763593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial skin cancers after kidney transplantation: a retrospective single-centre study of 376 recipients.
    Kaufmann RA; Oberholzer PA; Cazzaniga S; Hunger RE
    Eur J Dermatol; 2016 Jun; 26(3):265-70. PubMed ID: 26985913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Nonmelanoma Skin Cancer in Association With Use of Hydrochlorothiazide-Containing Products in the United States.
    Eworuke E; Haug N; Bradley M; Cosgrove A; Zhang T; Dee EC; Adimadhyam S; Petrone A; Lee H; Woodworth T; Toh S
    JNCI Cancer Spectr; 2021 Apr; 5(2):. PubMed ID: 33733052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States.
    D'Arcy ME; Pfeiffer RM; Rivera DR; Hess GP; Cahoon EK; Arron ST; Brownell I; Cowen EW; Israni AK; Triplette MA; Yanik EL; Engels EA
    JAMA Dermatol; 2020 Jul; 156(7):772-779. PubMed ID: 32401271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin cancers in renal transplant recipients: a description of the renal transplant cohort in Bern.
    Keller B; Braathen LR; Marti HP; Hunger RE
    Swiss Med Wkly; 2010; 140():w13036. PubMed ID: 20652847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological profile of nonmelanoma skin cancer in renal transplant recipients: experience of a referral center.
    Ferreira FR; Ogawa MM; Nascimento LF; Tomimori J
    An Bras Dermatol; 2014; 89(5):745-50. PubMed ID: 25184913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonmelanoma Skin Cancer Frequency and Risk Factors in Australian Heart and Lung Transplant Recipients.
    De Rosa N; Paddon VL; Liu Z; Glanville AR; Parsi K
    JAMA Dermatol; 2019 Jun; 155(6):716-719. PubMed ID: 30865218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased risk of squamous-cell carcinoma in simultaneous pancreas kidney transplant recipients compared with kidney transplant recipients.
    Wisgerhof HC; van der Boog PJ; de Fijter JW; Wolterbeek R; Haasnoot GW; Claas FH; Willemze R; Bouwes Bavinck JN
    J Invest Dermatol; 2009 Dec; 129(12):2886-94. PubMed ID: 19571820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keratinocyte Cancer Mortality in Kidney Transplant Recipients.
    Shao EX; Betz-Stablein B; Khosrotehrani K; Campbell S; Isbel N; Green AC
    Transplantation; 2022 May; 106(5):1078-1083. PubMed ID: 34049361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.
    Fortina AB; Piaserico S; Caforio AL; Abeni D; Alaibac M; Angelini A; Iliceto S; Peserico A
    Arch Dermatol; 2004 Sep; 140(9):1079-85. PubMed ID: 15381547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The presence of betapapillomavirus antibodies around transplantation predicts the development of keratinocyte carcinoma in organ transplant recipients: a cohort study.
    Genders RE; Mazlom H; Michel A; Plasmeijer EI; Quint KD; Pawlita M; van der Meijden E; Waterboer T; de Fijter H; Claas FH; Wolterbeek R; Feltkamp MCW; Bouwes Bavinck JN
    J Invest Dermatol; 2015 May; 135(5):1275-1282. PubMed ID: 25347116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
    Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
    JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.